Retinal Biologics Market Revenue, Driving Factors, Key Players, Strategies, Trends, Forecast Till 2027

 


According to MRFR analysis, the Global Retinal Biologics Market is expected to register a CAGR of 11.5% during the forecast period of 2020 to 2027 and is anticipated to reach USD 34,891.44 Million by 2027.

The growth of the Global Retinal Biologics Market is driven by various factors, such as the growing demand for effective biological drugs, rising research, and development activities to develop new drugs for ophthalmic conditions. Additionally, increasing strategic collaboration, expansion, and product launches by the companies also contribute to market growth. In August 2019, Regeneron Pharmaceuticals, Inc. received the US FDA approval for the EYLEA (aflibercept) injection prefilled syringe used for the treatment of retinal conditions. However, the ignorance of healthcare issues, lack of awareness about the new drugs available in the market in the developing countries hamper the market growth.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10171

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The retinal biologics market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The Americas is expected to be the largest market owing to the presence of a large number of, companies providing retinal biologics such as Regeneron Pharmaceuticals Inc. (US), Ocular Therapeutixc. (US), Spark Therapeutics (US), and many more. Additionally, the rising prevalence of diabetic retinopathy and the aging population supports the retinal biologics market in this region. For instance, currently, around 12 million people of 40 years and above has a vision problem in the US. A large number of vision problem cases and the presence of a number of manufacturing companies drive the market growth in this region. 

The European Retinal biologics market is the second-largest market, and it has been categorized as Western Europe and Eastern Europe. The Western European market has further been divided as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The increasing R&D to develop novel retinal biologics, and growing product approval boosts the market growth. Moreover, the increasing cases of macular degeneration, diabetic retinopathy, and uveitis among the population support market growth.

The retinal biologics market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. According to the World Blind Union Asia Pacific Region 2018, it was reported that in China, more than 35 million people have some disability out of which 17.5 million are vision impairment which includes blind people with various disabilities. The increasing geriatric population will lead to an increase in age-related macular degeneration which will, in turn, increase the patient population.

The retinal biologics market in the Middle East & Africa has been divided into the Middle East and Africa. The growing number of research laboratories in this region drives market growth. The increasing adaption of innovative treatment methods drives the market growth.

Segmentation

Global Retinal Biologics Market has been segmented based on Drug Class, Indication, and Distribution Channel.

Global Retinal Biologics Market has been segmented, on the basis on drug class, into TNF-α inhibitor and VEGF-A antagonist.

 On the basis of indication, the market is segmented into macular degeneration, diabetic, retinopathy, uveitis, and others.

On the basis of distribution channel, the market is segmented into hospitals and clinics, pharmacies, and others.

Key Players

Some of the Key Players in the Global Retinal Biologics Market are Regeneron Pharmaceuticals Inc. (US), Ocular Therapeutixc (US), Spark Therapeutics (US), F. Hoffmann-La Roche Ltd (Basel, Switzerland), AbbVie Inc. (US), Johnson & Johnson Services, Inc. (US), Amgen Inc. (US), MeiraGTx Limited (US) and many more.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/retinal-biologics-market-10171

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Have a Look at Related Reports:

Orthopedic Biomaterial Market

Brachytherapy Market

Media sera and Reagents - Cell culture Market

Circulating Tumor Cell Market

Capnography Market

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

ICP-OES Spectrometer Industry Size, Share, Key Players, Growth Trend, and Forecast Till 2030

Image
  The global  ICP-OES Spectrometer Industry  was valued at USD 521.4 million in 2018 at a CAGR of 7.2% during the forecast period of 2019 to 2025. ICP-OES Spectrometer is an analytical instrument that is used for the detection of chemical elements. It uses the technique of inductively coupled plasma optical emission spectroscopy (ICP-OES) for carrying out its analysis procedure. Certain factors that propel the growth of the ICP-OES Spectrometer Industry include increasing R&D expenditure for the development of better analytical systems and growing technological advancements. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8120 However, the high cost of instruments and requirement of large capital investment for setting up instrument manufacturing plants is hindering the growth of the global ICP-OES Spectrometer Industry in the forecast period. Currently, the global ICP-OES Spectrometer Industry is dominated by several players. ...
Read more

Opioid Withdrawal Treatment Market Growth, Size Analysis, DROT, PEST, Porter’s, Region & Country Forecast Till 2030

Image
The global  opioid withdrawal treatment growth market held a market value of USD 1.8 billion in 2018 and is projected to grow at a CAGR of 10.1% over the forecast period. Opioids are drugs such as heroin, opium, morphine, codeine, and methadone that are used in cases of severe, postsurgical, or chronic pain. In some cases, usage of opioids causes addiction, and Opioid withdrawal syndrome is a life-threatening condition resulting from opioid dependence. These drugs can also cause severe health problems and sometimes even result in overdose and loss of life. Hence this opioid dependence requires treatment, which is known as opioids withdrawal treatment. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8123 Segmentation The global opioid withdrawal treatment market has been segmented into drug type and distribution channel. By drug type, the market has been segmented into the nonsteroidal anti-inflammatory drugs, anti-nausea medications, a...
Read more

Preclinical Imaging Market Trends, Size, Key Factors, Major Players, Growth Strategies, Forecast Till 2027

Image
Preclinical Imaging Market Trends , Revenue Forecast, Competitive Landscape, Growth Factors, and Research Report: by Product (Optical Imaging, Nuclear Imaging, Micro-MRI, Micro-Ultrasound, Micro-CT, Photoacoustic Imaging System), by Reagent (Optical, Nuclear, CT Contrast Agents, MRI Contrast Agents) The global preclinical imaging anticipated to have held a market value of USD 2.01 billion in the year 2017 and is expected to grow at a CAGR of 6.3% during the forecast period. Preclinical imaging solutions are used during the preclinical research for visualization of living animals. It is playing important role during drug development process. It is evaluating the effectiveness and safety of new treatments and describing drug distribution patterns before clinical use. preclinical imaging solutions has broad application field such as, neurology; cardiology; inflammation; infectious diseases; cancer research; functional and anatomical neuroimaging, orthopedics; and cardiac imaging. Requ...
Read more